HER2 Support Group Forums - Exelixis reports interim data of XL184 for metastatic castration-resistant prostate c

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - Exelixis reports interim data of XL184 for metastatic castration-resistant prostate c (https://her2support.org/vbulletin/showthread.php?t=47646)

News	11-18-2010 01:33 AM

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate c

Exelixis, Inc. today reported interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

More...

All times are GMT -7. The time now is 11:18 PM.